A Breath of Hope Lung Cancer Foundation

Hope Glows! On Nov 7 - 35W Bridge, Lowry Bridge, and IDS Tower will glow white, blue, and yellow in recognition of A Breath of Hope and Lung Cancer Awareness Month.

Hope Glows represent the patients, survivors, caregivers, families, and loved ones impacted by lung cancer.

Test it. Target it. Treat it. Webinar on biomarker testing and personalized lung cancer care w/ @lungoncdoc

Nov. 9 | 6 PM CST
Register: zoom.us/webinar/regist…

Sponsored by Nuvation Bio.

ASCO 2026 : More than 1/2 with advanced ALK+ lung cancer treated with lorlatinib remained progression-free after 7 years. 55% didn't see their cancer worsen. One of the longest-lasting benefits ever reported for advanced lung cancer.
#ALKPositive #LungCancer #ASCO2026

🚨 ASCO 2026: 83% reduction in the risk of recurrence or death researchers found with selpercatinib for patients with early-stage RET+ lung cancer. 92% recurrence-free at 2 years. A major step toward preventing lung cancer from coming back.
#ASCO2026 #LungCancer #RETPositive

Straight from ASCO 2026: Targeted therapy sunvozertinib showed better results than chemo for patients with EGFR Exon 20 insertion-positive lung cancer. Longer progression-free survival Nearly double the response rate. Biomarker-driven treatment matters. #LungCancer #ASCO2026